Riskpilot← Back to searchSign inGet full accessStjernquist Medical AB
ABActiveOrg 5592766132Päronvägen 31Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2025
SEK 535K
-33% vs 2024
EBITDA margin
80.7%
-17% vs 2024
Equity ratio
48.4%
Financial strength
Net profit 2025
SEK 414K
+25% vs 2024
| Revenue | SEK 535K | -33% |
| EBITDA | SEK 432K | -17% |
| Net profit | SEK 414K | +25% |
| Total assets | SEK 2,3M | +19% |
| Equity | SEK 1,1M | +22% |
| Employees | 0 | — |
Legal name
Stjernquist Medical AB
Org number
5592766132
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 oktober 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget skall bedriva läkarmottagning samt undervisning i medicin samt annan härmed förenlig verksamhet. Bolaget skall dessutom handla och förvalta värdepapper.
Address
Päronvägen 31
Email
martin.stjernquist@med.lu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 708 | 715 | 786 | 796 | 535 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 486 | 352 | 406 | 521 | 432 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 486 | 352 | 406 | 521 | 432 |
| Net financials | — | 32 | −42 | −79 | 267 |
| Profit before tax | 1 115 | 289 | 312 | 421 | 525 |
| Tax | −230 | −60 | −66 | −90 | −111 |
| Net profit | 885 | 229 | 246 | 331 | 414 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 973 | 1 944 | 1 932 | 1 940 | 2 316 |
| Equity | 910 | 946 | 1 005 | 921 | 1 120 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 691 | 530 | 353 | 305 | 308 |
| Total debt | 691 | 530 | 353 | 305 | 308 |
EBITDA margin
80.7%
This company
15.8%
Market median
+411% vs market
20212025
Equity ratio
48.4%
This company
38.2%
Market median
+27% vs market
20212025
Return on equity
37.0%
This company
18.4%
Market median
+101% vs market
20212025
Net profit margin
77.4%
This company
8.1%
Market median
+856% vs market
20212025
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Stjernquist Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Otto Christer Smith | Deputy Board Member | 0 companies |
| Carin Birgitta Stjernquist | Deputy Board Member | 0 companies |
| Martin H N Stjernquist | Board of Directors | 0 companies |